Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei
about
Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans.Role of EspB in experimental human enteropathogenic Escherichia coli infection.Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults.Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adultsMolecular cloning and characterization of genes for Shigella sonnei form I O polysaccharide: proposed biosynthetic pathway and stable expression in a live salmonella vaccine vectorGenetic control of antibody responses induced against an antigen delivered by recombinant attenuated Salmonella typhimuriumAntigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates.Standardization of measurement of immunoglobulin-secreting cells in human peripheral circulation.Control by H-2 genes of the Th1 response induced against a foreign antigen expressed by attenuated Salmonella typhimuriumSafety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG.Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system.Virulence plasmid instability in Shigella flexneri 2a is induced by virulence gene expressionEvaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine.Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.Enteric pathogens as vaccine vectors for foreign antigen deliveryClinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen.Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine.Small-animal model to measure efficacy and immunogenicity of Shigella vaccine strains.Immunogenicity of Salmonella typhi Ty21a vaccine for young childrenEstablishment of a Shigella sonnei human challenge model in Thailand.Presence of specific immunoglobulin A-secreting cells in peripheral blood after natural infection with Shigella sonneiSecretory IgA: arresting microbial pathogens at epithelial borders.Evaluation of an intragastric challenge model for Shigella dysenteriae 1 in rhesus monkeys (Macaca mulatta) for the pre-clinical assessment of Shigella vaccine formulations.Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers.Secondary Vibrio cholerae-specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: changes with time and lack of correlation with protectionTwo studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers.
P2860
Q33876803-0B020862-9EEE-4D4C-A5BA-1CFB503B6017Q34003433-DFAF726C-F244-4A82-AAD2-E6C9551CEAE0Q34004849-9F183D38-3ED2-4DA6-B99A-DE91FBF067B2Q34006013-F82954B7-D05A-47E7-891A-77F4D9C6B2D3Q34120926-41A81CD3-D5D9-4D21-8DE7-8A53E7ADB5C4Q34129475-55C07301-0B0A-46B7-BEAF-134CED7578C0Q34540355-13E74006-2F22-4979-8493-375BFCE37374Q34809879-C7455E33-30A2-4228-B6AF-45C85BBC5050Q35229764-67DEFF36-8E15-46AC-A2DF-4495B090BE7DQ35527181-76ECC515-8A3B-4EAB-BD8A-33D4BC96934FQ35528270-4CFBE2C6-BEA5-4B2C-B751-5FC07740B478Q35553394-44AE0C58-6384-4F3F-91D9-771093CBD932Q35554877-0C58F6EC-1C0F-435D-93A1-E1543F77CC8CQ35604978-15832D5F-8D46-4D04-8320-9F4A9704F01EQ35677333-38501174-91A1-4E32-B9E5-423B4C2A83F1Q35896020-2FAB46D7-4D8B-4E7A-BA28-E244655E9AB5Q36844719-F46107E4-6329-4F46-835A-2DE6C6B3F260Q36945836-65687B21-1B2D-4A63-852A-E768FFF36550Q36946919-E91B92A9-4C52-45DC-89E9-D2B4740DA7C1Q36989057-053FCC4D-BA35-48F4-83F6-08C2E0237F4DQ36989511-767248E7-C0EB-448B-B68B-8C43D4EA6FC5Q37066116-6C18A8F8-0A79-4FE8-A8FC-F1D3AAC44B4FQ37125747-4469E6E1-03E9-417A-9128-AD44D8A301DEQ37175693-E2F90752-D1DC-472C-8504-E5DC64C4A79AQ37638547-7D5A35DC-F7FC-4639-A241-80694396BD32Q40149266-45BD1A86-7598-48F0-BEA7-146B5787ED48Q40374066-B0B5258C-3CCA-480F-897E-CC45DE5F964FQ40469794-81A28BF9-3BA9-4D5D-831B-0A7061607440
P2860
Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Specific immunoglobulin A-secr ...... ection by pathogenic S. sonnei
@en
type
label
Specific immunoglobulin A-secr ...... ection by pathogenic S. sonnei
@en
prefLabel
Specific immunoglobulin A-secr ...... ection by pathogenic S. sonnei
@en
P2093
P2860
P1476
Specific immunoglobulin A-secr ...... ection by pathogenic S. sonnei
@en
P2093
D A Herrington
J R Murphy
L Van de Verg
M M Levine
S B Formal
S S Wasserman
P2860
P304
P407
P577
1990-06-01T00:00:00Z